Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.
2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges
Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members
3 Cash-Producing Stocks That Concern Us
New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment
Labcorp Holdings has lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.
BURLINGTON, N.C. , May 20, 2026 /PRNewswire/ --Â Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of MyLabcorp ...
3 Profitable Stocks We Find Risky
3 Healthcare Stocks We Steer Clear Of
The 5 Most Interesting Analyst Questions From Labcorp’s Q1 Earnings Call